more_reports

Pulmatrix Inc.

PULM:NASDAQ

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE technology.

streetwise book logo Streetwise Company Fact Sheet

2024/7/14 1:11:43

(PULM:NASDAQ)